Reaction

Neck Injury reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,908 reports · 98 co-occurring drugs

As of the last recalculation, Neck Injury appears in 2,908 FAERS reports alongside 98 co-occurring drug terms. The strongest observed disproportionality signal is OXYMORPHONE HYDROCHLORIDE (PRR 21.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Oxymorphone Hydrochloride	35	21.7	21.8
Calcium, Magnesium, Potassium, And Sodium Oxybates	20	16.7	16.8
Methocarbamol	37	11.8	11.8
Carisoprodol	31	11.7	11.8
Meclizine Hcl 12.5Mg	22	11.6	11.6
Meclizine Hcl 25Mg	22	11.6	11.6
Meclizine Hcl 12.5 Mg	22	11.6	11.6
Meclizine Hcl 25 Mg	22	11.6	11.6
Meclizine	24	10.6	10.6
Methocarbamol Tablets	24	10.3	10.3
Meclizine Hydrochloride	28	10.3	10.3
Naproxen Sodium Tablet, Coated	18	9.6	9.6
Naproxen Sodium, Coated Tablets	18	9.6	9.6
Naproxen Sodium 220Mg	18	9.6	9.6
Sodium Oxybate	83	9.2	9.3
Butalbital, Acetaminophen, And Caffeine	13	8.8	8.8
Cimetidine	11	8.2	8.2
Tramadol Hydrochloride	41	7.9	7.9
Amlodipine Besylate And Benazepril Hydrochloride	10	7.8	7.8
Cyclobenzaprine Hydrochloride	9	7.2	7.2
Modafinil	32	7.2	7.2
Fluticasone Furoate	12	7.1	7.1
Ziprasidone Mesylate	14	7.1	7.1
Cyclobenzaprine	47	6.8	6.8
Armodafinil	20	6.8	6.8
Tizanidine Hydrochloride	17	6.8	6.8
Buprenorphine Hydrochloride, Naloxone Hydrochloride	22	6.6	6.6
Ziprasidone	16	6.5	6.5
Hydrocodone Bitartrate And Acetaminophen	50	6.4	6.4
Naltrexone Hydrochloride And Bupropion Hydrochloride	7	5.9	5.9
Oxycodone And Acetaminophen	19	5.9	5.9
Liothyronine Sodium	7	5.8	5.8
Rizatriptan Benzoate	8	5.6	5.6
Tolterodine Tartrate	7	5.6	5.6
Ibuprofen And Diphenhydramine Citrate	18	5.6	5.6
Oxycodone And Acetaminophen Tablets	9	5.4	5.4
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	26	5.3	5.3
Mupirocin Calcium	10	5.2	5.2
Ezetimibe And Simvastatin	11	5.2	5.2
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate	28	4.9	4.9
Terazosin Hydrochloride	6	4.8	4.8
Tizanidine	16	4.8	4.8
Mupirocin	9	4.8	4.8
Glyburide	16	4.8	4.8
Ropinirole	10	4.7	4.7
Teriflunomide	29	4.6	4.6
Buspirone Hydrochloride	7	4.5	4.6
Raloxifene Hydrochloride	9	4.4	4.4
Conjugated Estrogens	35	4.3	4.3
Estradiol Gel 0.1%	27	4.3	4.3
Estradiol Transdermal	27	4.3	4.3
Cenobamate	5	4.3	4.3
Hydromorphone Hydrochloride	54	4.3	4.3
Eszopiclone	15	4.2	4.2
Mometasone Furoate And Formoterol Fumarate Dihydrate	9	4.1	4.1
Estrogens, Conjugated	34	4.1	4.1
Oxycodone Hydrochloride	121	4.1	4.1
Sumatriptan	21	4.0	4.0
Carboxymethylcellulose Sodium	5	3.8	3.8
Fremanezumab-Vfrm	6	3.7	3.7
Oxycodone Hydrochloride And Acetaminophen	51	3.7	3.7
Fentanyl Citrate	9	3.6	3.6
Oseltamivir Phosphate	12	3.5	3.5
Linaclotide	13	3.5	3.5
Naltrexone	15	3.5	3.5
Rimegepant Sulfate	6	3.4	3.4
Siponimod	4	3.2	3.2
Eptinezumab-Jjmr	4	3.1	3.2
Teriparatide	49	3.1	3.1
Emicizumab	5	2.9	2.9
Bosentan	20	2.9	2.9
Isotretinoin	19	2.8	2.8
Ranolazine	4	2.7	2.7
Inclisiran	3	2.7	2.7
Diclofenac Potassium	4	2.7	2.7
Diclofenac Potassium, Film Coated	3	2.6	2.6
Diclofenac Potassium Tablets	3	2.6	2.6
Interferon Beta-1A	67	2.5	2.5
Cannabidiol	8	2.5	2.5
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	14	2.4	2.4
Dalfampridine	24	2.4	2.4
Ethyl Alcohol	8	2.1	2.1
Varenicline Tartrate	23	2.1	2.1
Dimethyl Fumarate	34	2.0	2.0
Sacubitril And Valsartan	32	2.0	2.0
Emtricitabine And Tenofovir Alafenamide	3	1.9	1.9
Enzalutamide	15	1.8	1.8
Galcanezumab-Gnlm	8	1.8	1.8
Buprenorphine	23	1.8	1.8
Exenatide	13	1.8	1.8
Hydrocodone Bitartrate	10	1.6	1.6
Esketamine Hydrochloride	4	1.6	1.6
Onabotulinumtoxina	17	1.6	1.6
Patiromer	3	1.6	1.6
Dulaglutide	19	1.5	1.5
Tapentadol Hydrochloride	7	1.5	1.5
Erenumab-Aooe	11	1.4	1.4
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	4	0.9	0.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.